Effects of peptides: A cross-listing of peptides and their central actions published in the journal Peptides from 1994 through 1998

Peptides

Volumn 20, Issue 9, 1999, Pages 1127-1138

  Pan, Weihong ^a   Kastin, Abba J ^a   Banks, William A ^b   Zadina, James E ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Attention; Behavior; CNS; Drinking; EEG; Feeding; Grooming; Memory; Thermoregulation

Indexed keywords

BRAIN PEPTIDE; NEUROPEPTIDE; OCTADECANEUROPEPTIDE;

CENTRAL NERVOUS SYSTEM; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW;

PEPTIDES;

EID: 0032851184     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(99)00109-6     Document Type: Review

References (166)

1. Aguila M.C. Somatostatin decreases somatostatin messenger ribonucleic acid levels in the rat periventricular nucleus. Peptides. 19:1998;1573-1579.
2. Ahmed B, Kastin AJ, Banks WA, Zadina JE. CNS effects of peptides: a cross-listing of peptides and their central actions published in the journal Peptides 1986-1993. Peptides 1994:15:1105-55.
3. Albers H.E., Cooper T.T. Effects of testosterone on the behavioral response to arginine vasopressin microinjected into the central gray and septum. Peptides. 16:1995;269-273.
4. Albers H.E., Karom M., Whitman D.C. Ovarian hormones alter the behavioral response of the medial preoptic anterior hypothalamus to arginine-vasopressin. Peptides. 17:1996;1359-1363.
5. Aramakis V.B., Stanley B.G., Ashe J.H. Neuropeptide Y receptor agonists multiple effects on spontaneous activity in the paraventricular hypothalamus . Peptides. 17:1996;1349-1357.
6. Arvat E., Di Vito L., Maccagno B., Broglio F., Boghen M.F., Dehenghi R., Camanni F., Ghigo E. Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH. Peptides. 18:1997;885-891.
7. Asakawa A., Inui A., Momose K., Ueno N., Fujino M.A., Kasuga M. Motilin increases food intake in mice. Peptides. 19:1998;987-990.
8. Asarian L., Eckel L.A., Geary N. Behaviorally-specific inhibition of sham feeding by amylin. Peptides. 19:1998;1711-1718.
9. Au C.L., Canny B.J., Farnworth P.G., Giraud A.S. Bombesin regulation of adrenocorticotropin release from ovine anterior pituitary cells. Peptides. 18:1997;995-1000.
10. Barbieri M., Nistri A. Effects of the neuropeptide thyrotropin-releasing hormone on GABAergic synaptic transmission of CA1 neurons of the rat hippocampal slice during hypoxia. Peptides. 18:1997;585-591.
11. Barton C., York D.A., Bray G.A. Opioid receptor subtype control of galanin-induced feeding. Peptides. 17:1996;237-240.
12. 5]enkephalin on the concentration of cGMP in brain regions and spinal cord of the mouse. Peptides. 18:1997;1629-1634.
13. 5]enkephalin on the activity of nitric oxide synthase in brain regions and spinal cord in mice. Peptides. 19:1998;113-117.
14. 4]deltorphin II in mice. Peptides. 18:1997;1609-1613.
15. Boer G.J., Quak J., de Vries M.C., Heinsbroek R.P.W. Mild sustained effects of neonatal vasopressin and oxytocin treatment on brain growth and behavior of the rat. Peptides. 15:1994;229-236.
16. Bouali S.M., Fournier A., St. Pierre S., Jolicoeur F.B. In vivo central actions of NPY (1-30), an N-terminal fragment of neuropeptide Y. Peptides. 15:1994;799-802.
17. Braida D., Paladini E., Gori E., Sala M. Naltrexone, naltrindole, and CTOP block cocaine-induced sensitization to seizures and death. Peptides. 18:1997;1189-1195.
18. Broccardo M., Improta G., Brandoni A., Tabacco A. Effect of PG-SPI and PG-KII, two novel and natural tachykinins, on salivary secretion in the rat. Peptides. 17:1996;729-731.
19. Brown C.M., Fletcher P.J., Coscina D.V. Neuropeptide Y-induced operant responding for sucrose is not mediated by dopamine. Peptides. 19:1998;1667-1673.
20. Bruneau G., Tillet Y. Localization of the preprosomatostatin-mRNA by in situ hybridization in the ewe hypothalamus. Peptides. 19:1998;1749-1758.
21. Bull D.F., Husband A.J., Munro K.I., Exton M.S., Pfister H.P., King M.G. Inhibition of endotoxin-induced temperature change by behavioral conditioning using α-melanocyte-stimulating hormone as an unconditioned stimulus. Peptides. 15:1994;139-142.
22. Chance W.T., Balasubramaniam A., Thompson H., Mohapatra B., Ramo J., Fisher J.E. Assessment of feeding response of tumor-bearing rats to hypothalamic injection and infusion of neuropeptide Y. Peptides. 17:1996;797-801.
23. Chance W.T., Thompson H., Thomas I., Fischer J.E. Anorectic and neurochemical effects of pituitary adenylate cyclase activating polypeptide in rats. Peptides. 16:1995;1511-1516.
24. Charles C.J., Espiner E.A., Richards A.M., Donald R.A. Central C-type natriuretic peptide augments the hormone response to hemorrhage in conscious sheep. Peptides. 16:1995;129-132.
25. Ciccocioppo R., Panocka I., Polidori C., De Caro G., Regoli D., Massi M. Stimulation of tachykinin NK-3 receptors in the nucleus basalis magnocellularis reduces alcohol intake in rats. Peptides. 18:1997;1349-1355.
26. Ciccocioppo R., Panocka I., Pompei P., Polidori C., De Caro G., Massi M. Subcutaneous (s.c.) injections of the tachykinin senktide reduce alcohol intake in alcohol-preferring rats. Peptides. 16:1995;533-537.
27. Clementi G., Valerio C., Emmi I., Prato A., Drago F. Behavioral effects of amylin injected intracerebroventricularly in the rat. Peptides. 17:1996;589-591.
28. Covasa M., Ritter R.C. Rats maintained on high-fat diets exhibit reduced satiety in response to CCK and bombesin. Peptides. 19:1998;1407-1415.
29. Cremer C., de Bariglio S.R., Civallero G., Celis M.E. α-MSH-induced behavior changes after diazepam and baclofen administration related with cyclic AMP levels . Peptides. 16:1995;821-825.
30. Cummings S.L., Truong B.G., Gietzen D.W. Neuropeptide Y and somatostatin in the anterior piriform cortex alter intake of amino acid-deficient diets. Peptides. 19:1998;527-535.
31. Currie P.J., Coscina D.V. Dissociated feeding and hypothermic effects of neuropeptide Y in the paraventricular and perifornical hypothalamus. Peptides. 16:1995;599-604.
32. De Caro G., Polidori C., Beltz T.G., Johnson A.K. Area postrema, lateral parabrachial nucleus, and the antinatriorexic effect of bombesin. Peptides. 19:1998;1399-1406.
33. De Mateos-Verchere J.G., Leprince J., Tonon M.-C., Vaudry H., Costentin J. The octadecaneuropeptide ODN induces anxiety in rodents possible involvement of a shorter biologically active fragment . Peptides. 19:1998;841-848.
34. de Pedro N., Cespedes M.V., Delgado M.J., Alonso-Bedate M. Mu-opioid receptor is involved in β-endorphine-induced feeding in goldfish. Peptides. 17:1996;421-424.
35. de Pedro N., Pinillos M.L., Valenciano A.I., Alonso-Bedate M., Delgado M.J. Inhibitory effect of serotonin on feeding behavior in goldfish involvement of CRF . Peptides. 19:1998;505-511.
36. Dickson P.R., Feifel D., Vaccarino F.J. Blockade of endogenous GRF at dark onset selectively suppresses protein intake. Peptides. 16:1995;7-9.
37. Dickson P.R., Vaccarino F.J. GRF-induced feeding evidence for protein selectivity and opiate involvement . Peptides. 15:1995;1343-1352.
38. 3]β-casomorphin (2-5) on cortical EEG power spectra in rats. Peptides. 15:1994;667-670.
39. Dluzen D.E., Muraoka S., Engelmann M., Landgraf R. The effects of infusion of arginine vasopressin, oxytocin, or their antagonists into the olfactory bulb upon social recognition responses in male rats. Peptides. 19:1998;999-1005.
40. Drago F., Stanciu M., Salehi S., Scapagnini U. The block of central vasopressin V1 but not V2 receptors suppresses grooming behavior and hypothermia induced by intracerebroventricular vasopressin in male rats. Peptides. 18:1997;1389-1392.
41. 1A agonist flesinoxan on hypothalamic neuropeptide Y in the rat evidence that NPY may mediate serotonin's effects on food intake . Peptides. 17:1996;943-949.
42. 11] neurotensin during the semichronic intracerebroventricular infusion of the peptide in rats. Peptides. 15:1994;303-307.
43. Dulawa S.C., Vanderweele D.A. Cholecystokinin and estradiol synergistically potentiate satiety in rats. Peptides. 15:1994;913-918.
44. Dyer J.K., Philipsen H.L.A., Tonnaer J.A.D.M., Hermkens P.H.H., Haynes L.W. Melanocortin analogue Org2766 binds to rat Schwann cells, upregulates NGF low-affinity receptor p75, and releases neurotrophic activity. Peptides. 16:1995;515-522.
45. Emel'Yanova T.G., Usenko A.B., Deigin V.I., Yarova E.P., Kamensky A.A. Effect of dermorphin on thermoregulation in rats at selected ambient temperatures. Peptides. 17:1996;241-245.
46. Ervin G.N., Mosher J.T., Birkemo L.S., Johnson M.F. Multiple, small doses of cholecystokinin octapeptide are more efficacious at inducing taste aversion conditioning than single, large doses. Peptides. 16:1995;539-545.
47. Evans J.J., Tulloch S. Effects of administration of oxytocin in association with gonadotropin-releasing hormone on luteinizing hormone levels in rats in vivo. Peptides. 16:1995;145-150.
48. Feifel D., Reza T.L., Robeck S.L. Pro-dopamine effects of neurotensin on sensorimotor gating deficits. Peptides. 18:1997;1457-1460.
49. Floody O.R., Cooper T.T., Albers H.E. Injection of oxytocin into the medial preoptic-anterior hypothalamus increases ultrasound production by female hamsters. Peptides. 19:1998;833-839.
50. Flynn F.W. Mammalian bombesin-like peptides suppress sham drinking of salt by sodium-deficient rats. Peptides. 17:1996;951-956.
51. Fontana F., Bernardi P., Merlo Pich E., Tartuferi L., Boschi S., De Iasio R., Spampinato S. Opioid peptides in response to mental stress in asymptomatic dilated cardiomyopathy. Peptides. 19:1998;1147-1153.
52. Franci C.R., Anselmo-Franci J.A., McCann S.M. Angiotensinergic neurons physiologically inhibit prolactin, growth hormone, and thyroid-stimulating hormone, but not adrenocorticoptropic hormone, release in ovariectomized rats. Peptides. 18:1997;971-976.
53. 2). Peptides. 15:1994;1505-1511.
54. Gerhardt P., Voits M., Fink H., Huston J.P. Evidence for mnemotropic action of cholecystokinin fragments Boc-CCK-4 and CCK-8s. Peptides. 15:1994;689-697.
55. Gonzales M.I., Baker B.I., Hole D.R., Wilson C.A. Behavioral effects of neuropeptide E-I (NEI) in the female rat interactions with α-MSH, MCH and dopamine . Peptides. 19:1998;1007-1016.
56. Gonzalez M.I., Kalia V., Hole D.R., Wilson C.A. α-Melanocyte-stimulating hormone (α-MSH) and melanin-concentrating hormone (MCH) modify monoaminergic levels in the preoptic area of the rat. Peptides. 18:1997;387-392.
57. Gonzalez M.I., Vaziri S., Wilson C.A. Behavioral effects of α-MSH and MCH after central administration in the female rat. Peptides. 17:1996;171-177.
58. Goodman C.B., Emilien B., Partilla J.S., Yang H.-Y.T., Lee C.-H., Cadet J.L., Heyliger S., Rothman R. Regulation of μ binding sites after chronic administration of antibodies directed against specific anti-opiate peptides. Peptides. 19:1998;1703-1709.
59. Groneveld D., Balm P.H.M., Wendelaar Bonga S.E. Biphasic effect of MCH on α-MSH release from the tilapia (Oreochromis mossambicus) pituitary. Peptides. 16:1995;945-949.
60. Guidobono F., Coluzzi M., Pagani F., Pecile A., Netti C. Amylin given by central and peripheral routes inhibits acid gastric secretion. Peptides. 15:1994;699-702.
61. Harel G., Shamoun D.S., Kane J.P., Magner J.A., Szabo M. Prolonged effects of tumor necrosis factor (TNF)-α on anterior pituitary hormone release. Peptides. 16:1995;641-645.
62. Heinrichs S.C., Vale E.A., Lapsansky J., Behan D.P., McClure L.V., Ling N., De Souza E.B., Schulteis G. Enhancement of performance in multiple learning tasks by corticotropin-releasing factor-binding protein ligand inhibitors. Peptides. 18:1997;711-716.
63. Houpt T.A., Corp E.S., Berlin R. Intracerebroventricular angiotensin II increases intraoral intake of water in rats. Peptides. 19:1998;171-173.
64. Huhman K.L., Albers H.E. Neuropeptide Y microinjected into the suprachiasmatic region phase shifts circadian rhythms in constant darkness. Peptides. 15:1994;1475-1478.
65. Hwa J.J., Ghibaudi L., Williams P., Witten M.B., Tedesco R., Strader C.D. Differential effects of intracerebroventricular glucagon-like peptide-1 on feeding and energy expenditure regulation. Peptides. 19:1998;869-875.
66. Isobe Y., Nishino H. AVP rhythm in the suprachiasmatic nucleus in relation to locomotor activity under constant light. Peptides. 19:1998;827-832.
67. Joanny P., Steinberg J., Oliver C., Grino M. Effect of excitatory amino acids on rat hypothalamic somatostatin secretion in vitro. Peptides. 18:1997;1039-1043.
68. Kavaliers M., Choleris E., Saucier D.M. The NMDA receptor antagonist, NPC 12626, reduces the pronociceptive effects of orphanin FQ and kappa opiate antinociception in the land snail, Cepaea nemoralis. Peptides. 18:1997;943-947.
69. Kavaliers M., Perrot-Sinal T.S. Pronociceptive effects of the neuropeptide, nociceptin, in the land snail, Cepaea nemoralis. Peptides. 17:1996;763-768.
70. Kennedy B.P., Mahata S.K., O'Connor D.T., Ziegler M.G. Mechanism of cardiovascular actions of the chromogranin A fragment catestatin in vivo. Peptides. 19:1998;1241-1248.
71. Kistler-Heer V., Schlumpf M., Lichtensteiger W. Melanocortin and MCH percursor-derived NEI effects on striatum-midbrain co-cultures. Peptides. 19:1998;1317-1327.
72. Klapdor K., Sprick U., Huston J.P. Attenuation of hippocampal kainic acid-induced seizures by substance P treatment. Peptides. 15:1994;425-427.
73. Klemfuss H., Southerland S., Britton K.T. Cardiovascular actions of neuropeptide Y and social stress. Peptides. 19:1998;85-92.
74. Knigge K.M., Wagner J.E. Melanin-concentrating hormone (MCH) involvement in pentylenetetrazole (PTZ)-induced seizure in rat and guinea pig. Peptides. 18:1997;1095-1097.
75. 2-adrenergic and μ-opioid spinal antinociception by neuropeptide FF. Peptides. 16:1995;973-977.
76. Kovacs A., Telegdy G. Modulation of active avoidance behavior of rats by icv administration of CGRP antiserum. Peptides. 15:1994;893-895.
77. Kovacs A., Telegdy G., Toth G., Penke B. The involvement of nitric oxide (NO) in the CGRP-induced behavior of rats. Peptides. 17:1996;1183-1187.
78. Ku Y.-H., Tan L., Li L.-S., Ding X. Role of corticotropin-releasing factor and substance P in pressor responses of nuclei controlling emotion and stress. Peptides. 19:1998;677-682.
79. Larsson J.E., Koskinen L.-O.D., Wahlstrom G. Effects of TRH and atropine on induction and duration of anesthesia with propofol in rats. Peptides. 17:1996;293-297.
80. Lin L., Chen J., York D.A. Chronic icv enterostatin preferentially reduced fat intake and lowered body weight. Peptides. 18:1997;657-661.
81. Lin L., Umahara M., York D.A., Bray G.A. β-Casomorphins stimulate and enterostatin inhibits the intake of dietary fat in rats. Peptides. 19:1998;325-331.
82. Lin L., York D.A. Enterostatin actions in the amygdala and PVN to suppress feeding in the rat. Peptides. 18:1997;1341-1347.
83. Lin L., York D.A. Changes in the microstructure of feeding after administration of enterostatin into the paraventricular nucleus and the amygdala. Peptides. 19:1998;557-562.
84. Lutz T.A., Del Prete E., Scharrer E. Subdiaphragmatic vagotomy does not influence the anorectic effect of amylin. Peptides. 16:1995;457-462.
85. Lutz T.A., Del Prete E., Szabady M.M., Scharrer E. Attenuation of the anorectic effects of glucagon, cholecystokinin, and bombesin by the amylin receptor antagonist CGRP (8-37). Peptides. 17:1996;119-124.
86. Lutz T.A., Del Prete E., Walzer B., Scharrer E. The histaminergic, but not the serotoninergic, system mediates amylin's anorectic effects. Peptides. 17:1996;1317-1322.
87. Lutz T.A., Pieber T.R., Walzer B., Del Prete E., Scharrer E. Different influence of CGRP (8-37), an amylin and CGRP antagonist, on the anorectic effects of cholecystokinin and bombesin in diabetic and normal rats. Peptides. 18:1997;643-649.
88. Lutz T.A., Rossi R., Althaus J., Del Prete E., Scharrer E. Amylin more potently reduces food intake than calcitonin gene-related peptide (CGRP) when injected into the lateral brain ventricle in rats. Peptides. 19:1998;1533-1540.
89. Lutz T.A., Senn M., Althaus J., Del Prete E., Ehrensperger F., Scharrer E. Lesion of the area postrema/nucleus of the solitary tract (AP/NTS) attenuates the anorectic effects of amylin and calcitonin gene-related peptide (CGRP) in rats. Peptides. 19:1998;309-317.
90. Malabu U.H., Kilpatrick A., Ware M., Vernon R.G., Williams G. Increased neuropeptide Y concentrations in specific hypothalamic regions of lactating rats possible relationship to hyperphagia and adaptive changes in energy balance . Peptides. 15:1994;83-87.
91. Malin D.H., Lake J.R., Jones J.A., Morel J., Moon W.D., Corbit B.P., Smith D.A., Claunch A.E., Kacher D., Stevens P.A., Webb S.L. Nitric oxide synthesis inhibition attenuates behavioral actions of neuropeptide FF. Peptides. 17:1996;615-618.
92. Marcos P., Corio M., Covenas R., Tramu G. Neurotensin and tyrosine hydroxylase in the tuberoinfundibular system of the guinea pig hypothalamus with special emphasis to lactation status. Peptides. 17:1996;139-146.
93. Martin-Schild S., Gerall A.A., Kastin A.J., Zadina J.E. Endomorphin-2 is an endogenous opioid in primary sensory afferent fibers. Peptides. 19:1998;1783-1789.
94. McBride R.B., Beckwith B.E., Swenson R.R., Sawyer T.K., Hadley M.E., Matsunaga T.O., Hruby V.J. The actions of melanin-concentrating hormone (MCH) on passive avoidance in rats a preliminary study . Peptides. 15:1994;757-759.
95. Meereis-Schwanke K., Klonowski-Stumpe H., Herberg L., Niederau C. Long-term effects of CCK-agonist and -antagonist on food intake and body weight in Zucker lean and obese rats. Peptides. 19:1998;291-299.
96. Merali Z., Plamondon H. Pharmaco-ontogenic modulation of feeding by oxytocin, bombesin, and their antagonists. Peptides. 17:1996;1119-1126.
97. Mezzano V., Donoso V., Capurro D., Huidobro-Toro J.P. Increased neuropeptide Y pressor activity in Goldblatt hypertensive rats in vivo studies with BIBP 3226 . Peptides. 19:1998;1227-1232.
98. Miller M., Haroutunian V., Wiltshire-Clement M. Altered alertness of vasopressin-secreting transgenic mice. Peptides. 16:1995;1329-1333.
99. 2 (PLG). Peptides. 18:1997;1209-1215.
100. Momose K., Inui A., Asakawa A., Ueno N., Nakajima M., Kasuga M. Anxiolytic effect of motilin and reversal with GM-109, a motilin antagonist, in mice. Peptides. 19:1998;1739-1742.
101. Morley J.E., Farr S.A., Flood J.F. Peripherally administered calcitonin gene-related peptide decreases food intake in mice. Peptides. 17:1996;511-516.
102. Mosher J.T., Birkemo L.S., Johnson M.F., Ervin G.N. Sulfated cholecystokinin (26-33) induces mild taste aversion conditioning in rats when administered by three different routes. Peptides. 19:1998;849-857.
103. B receptor subtypes in CCK-8-induced and LiCl-induced taste aversion conditioning. Peptides. 17:1996;483-488.
104. Murase T., Arima H., Kondo K., Oiso Y. Neuropeptide FF reduces food intake in rats. Peptides. 17:1996;353-354.
105. Murphy H.M., Babey E.M., Wideman C.H. Vasopressin deficiency and blood glucose interactions on passive avoidance behavior. Peptides. 15:1994;1335-1341.
106. Murphy H.M., Wideman C.H., Nadzam G.R. The interaction of vasopressin and the photic oscillator in circadian rhythms. Peptides. 17:1996;467-475.
107. Murphy H.M., Wideman C.H., Nadzam G.R. The role of vasopressin in modulating circadian rhythm responses to phase shifts. Peptides. 19:1998;1191-1208.
108. Murphy H.M., Wideman C.H., Row J.P. Vasopressin, immobilization, and the dexamethasone suppression test in rats. Peptides. 16:1995;437-440.
109. Nakajima M., Inui A., Asakawa A., Momose K., Ueno N., Teranishi A., Baba S., Kasuga M. Neuropeptide Y produces anxiety via Y2-type receptors. Peptides. 19:1998;359-363.
110. Nikolaus S., Huston J.P., Korber B., Thiel C., Schwarting R.K.W. Pretreatment with neurokinin substance P but not with cholecystokinin-8S can alleviate functional deficits of partial nigrostriatal 6-hydroxydopamine lesion. Peptides. 18:1997;1161-1168.
111. O-Lee T.J., Wei J.Y., Tache Y. Intracisternal TRH and RX 77368 potently activate gastric vagal efferent discharge in rats. Peptides. 18:1997;213-219.
112. Ookuma K., Barton C., York D.A., Bray G.A. Effect of enterostatin and κ-opioids on macronutrient selection and consumption. Peptides. 18:1997;785-791.
113. Owen D.B., Morley J.S., Ensor D.M., Allen Y.S., Miles J.B. Trophic effects of melanotropin-potentiating factor (MPF) on cultures of cells of the central nervous system. Peptides. 18:1997;1015-1021.
114. Panocka I., Ciccocioppo R., Polidori C., Angeletti S., De Caro G., Massi M. Sensitivity of brain sites to the inhibitory effect on alcohol intake of the tachykinin aminosenktide. Peptides. 19:1998;897-905.
115. Perras B., Molle M., Born J., Fehm H.L. Sleep and signs of attention during 3 months of intranasal vasopressin a pilot study in two elderly subjects . Peptides. 17:1996;1253-1255.
116. Pickavance L., Dryden S., Hopkins D., Bing C., Frankish H., Wang Q., Vernon R.G., William G. Relationships between hypothalamic neuropeptide Y and food intake in the lactating rat. Peptides. 17:1996;577-582.
117. Poggioli R., Benelli A., Arletti R., Cavazzuti E., Bertolini A. Nitric oxide is involved in the ACTH-induced behavioral syndrome. Peptides. 16:1995;1263-1268.
118. Pohl J., Arnold H., Schulz A., Pause B.M., Schulte H.M., Fehm-Wolfsdorf G. Modulation of pain perception in man by a vasopressin analogue. Peptides. 17:1996;641-647.
119. Polidori C., Ciccocioppo R., De Caro G., Massi M. Further evidence that central tachykinin NK-1 receptors mediate the inhibitory effect of tachykinins on angiotensin-induced drinking in rats. Peptides. 19:1998;149-155.
120. Polidori C., Recchi S., Venturi F., Ciccocioppo R., Massi M. Application of taste reactivity to study the mechanism of alcohol intake inhibition by the tachykinin aminosenktide. Peptides. 19:1998;1557-1564.
121. Reichel A., Begley D.J., Ermisch A. Changes in amino acid levels in rat plasma, cisternal cerebrospinal fluid, and brain tissue induced by intravenously infused arginine-vasopressin. Peptides. 16:1995;965-971.
122. Rice H.B., Corwin R.L. Intracerebroventricular enterostatin stimulates food intake in non-food-deprived rats. Peptides. 17:1996;885-888.
123. Rompre P-P. Psychostimulant-like effect of central microinjection of neurotensin on brain stimulation reward. Peptides. 16:1995;1417-1420.
124. Rushing P.A., Gibbs J. Prolongation of intermeal interval by gastrin-releasing peptide depends upon time of delivery. Peptides. 19:1998;1439-1442.
125. 1-27 in spontaneously feeding rats. Peptides. 19:1998;175-177.
126. Sanchez M., Baker B.I., Celis M. Melanin-concentrating hormone (MCH) antagonizes the effects of α-MSH and neuropeptide E-I on grooming and locomotor activities in the rat. Peptides. 18:1997;393-396.
127. Sarhan S., Hitchcock J.M., Grauffel C.A., Wettstein J.G. Comparative antipsychotic profiles of neurotensin and a related systemically active peptide agonist. Peptides. 18:1997;1223-1227.
128. Scalera G., Tarozzi G. Somatostatin administration modifies food intake, body weight, and gut motility in rat. Peptides. 19:1998;991-997.
129. Scalera G., Tarozzi G. Somatostatin administration alters taste preferences in the rat. Peptides. 19:1998;1565-1572.
130. Seifritz E., Muller M.J., Schonenberger G.A., Trachsel L., Hemmeter U., Hatzinger M., Ernst A., Moore P., Holsboer-Trachsler E. Human plasma DSIP decreases at the initiation of sleep at different circadian times. Peptides. 16:1995;1475-1481.
131. Shin H.C., Won C., Kwon J.W., Park H.J. Bombesin-induced changes of sensory transmission in the dorsal column nuclei. Peptides. 16:1995;31-35.
132. Shlik J., Koszycki D., Bradwejn J. Decrease in short-term memory function induced by CCK-4 in healthy volunteers. Peptides. 19:1998;969-975.
133. Shukla R., Rahmani N.H., Mizuma H., Srimal R.C., Prasad C. Role of endogenous cyclo (His-Pro) in cold-induced hypothermia in the desert rat (Mastonys natalensis). Peptides. 15:1994;1471-1474.
134. Shukla R., Srimal R.C., Prasad C. Cyclo(His-Pro) modulation of body temperature at hot ambient temperature in the desert rat (Mastomys natalensis). Peptides. 18:1997;689-693.
135. B antagonists role of the nucleus accumbens . Peptides. 17:1996;593-599.
136. Smith B.K., Berthoud H.-R., York D.A., Bray G.A. Differential effects of baseline macronutrient preferences on macronutrient selection after galanin, NPY, and an overnight fast. Peptides. 18:1997;207-211.
137. Smith B.K., York D.A., Bray G.A. Chronic cerebroventricular galanin does not induce sustained hyperphagia or obesity. Peptides. 15:1995;1267-1272.
138. 1-27, unlike bombesin, does not reduce sham feeding in rats. Peptides. 18:1997;1465-1467.
139. Socci D.J., Pert C.B., Ruff M.R., Arendash G.W. Peptide T prevents NBM lesion-induced cortical atrophy in aged rats. Peptides. 17:1996;831-837.
140. Sonti G., Ilyin S.E., Plata-Salaman C.R. Neuropeptide Y blocks and reverses interleukin-1 (IL-1)β-induced anorexia in rats. Peptides. 17:1996;517-520.
141. Sprick U., Hasenohrl R.U., Krauth J., Klapdor K., Huston J.P. Effects of chronic substance P treatment and intracranial fetal grafts on learning after hippocampal kainic acid lesions. Peptides. 17:1996;275-285.
142. Stocca G., Nistri A. The neuropeptide thyrotropin-releasing hormone modulates GABAergic synaptic transmission on pyramidal neurones of the rat hippocampal slice. Peptides. 17:1996;1197-1202.
143. Stratford T.R., Gibbs J., Smith G.P. Simultaneous administration of neuromedin B-10 and gastrin-releasing peptide (1-27) reproduces the satiating and microstructural effects of bombesin. Peptides. 17:1996;107-110.
144. Tsunashima K., Kato N., Masu A., Takahashi K. The effect of delta sleep-inducing peptide (DSIP) on the changes of body (core) temperature induced by serotonergic agonists in rats. Peptides. 15:1994;61-65.
145. Ukai M., Miura M., Kameyama T. Effects of galanin on passive avoidance response, elevated plus-maze learning, and spontaneous alternation performance in mice. Peptides. 16:1995;1283-1286.
146. Vaccarino F.J., Sovran P., Baird J.P., Ralph M.R. Growth hormone-releasing hormone mediates feeding-specific feedback to the suprachiasmatic circadian clock. Peptides. 16:1995;595-598.
147. Vaccarino F.J., Taube M.R. Intra-arcuate opiate actions stimulate GRF-dependent and protein-selective feeding. Peptides. 18:1997;197-205.
148. Voigt J.-P., Huston J.P., Voits M., Fink H. Effects of cholecystokinin octapeptide (CCK-8) on food intake in adult and aged rats under different feeding conditions. Peptides. 17:1996;1313-1315.
149. 1 receptors. Peptides. 19:1998;1031-1036.
150. Walter M.J., Scherrer J.F., Flood J.F., Morley J.E. Effects of localized injections of neuropeptide Y antibody on motor activity and other behaviors. Peptides. 15:1994;607-613.
151. Wayner M.J., Armstrong D.L., Phelix C.F. Nicotine blocks angiotensin II inhibition of LTP in the dendate gyrus. Peptides. 17:1996;1127-1133.
152. Wayner M.J., Polan-Curtain J., Armstrong D.L. Dose and time dependency of angiotensin II inhibition of hippocampal long-term potentiation. Peptides. 16:1995;1079-1082.
153. Weisinger R.S., Blair-West J.R., Burns P., Denton D.A., Tarjan E. Role of brain angiotensin in thirst and sodium appetite of rats. Peptides. 18:1997;977-984.
154. Wetzel W., Balschun D., Janke S., Vogel D., Wagner T. Effects of CLIP (corticotropin-like intermediate lobe peptide) and CLIP fragments on paradoxical sleep in rats. Peptides. 15:1994;237-241.
155. Wideman C.H., Murphy H.M., McCartney S.B. Interactions between vasopressin and food restriction on stress-induced analgesia. Peptides. 17:1996;63-66.
156. Williams C.L., Rosenfeld G.C., Burks T.F. Cholecystokinin-induced antinociception is not blocked by CCK-A or CCK-B receptor antagonists. Peptides. 18:1997;409-414.
157. Wu J.Y., Henins K.A., Gressens P., Gozes I., Fridkin M., Brenneman D.E., Hill J.M. Neurobehavioral development of neonatal mice following blockade of VIP during the early embryonic period. Peptides. 18:1997;1131-1137.
158. Yokoi H., Arima H., Kondo K., Murase T., Iwasaki Y., Yang H.-Y.T., Oiso Y. Antiserum against neuropeptide FF augments vasopressin release in conscious rats. Peptides. 19:1998;393-395.
159. Yu W.-Z., Bodnar R.J. Interactions between angiotensin II and delta opioid receptor subtype agonists upon water intake in rats. Peptides. 18:1997;241-245.
160. Yuan C.-S., Lowell T.K. Gastric and brain stem effects of substance P on nucleus tractus solitarius unitary responses. Peptides. 18:1997;1169-1173.
161. Zadina J.E., Banks W.A., Kastin A.J. Central nervous system effects of peptides, 1980-1985; a cross-listing of peptides and their central actions from the first six years of the journal, Peptides. Peptides. 7:1986;497-537.
162. 1-opioid receptor agonist. Peptides. 17:1996;233-236.
163. Zhou A.-W., Guo J., Wang H.-Y., Gu B.-X., Du Y-C. Enhancement of NGF gene expression in rat brain by the memory-enhancing peptide AVP (4-8). Peptides. 16:1995;581-586.
164. Zhou A.-W., Li W.-X., Guo J., Du Y-C. Facilitation of AVP (4-8) on gene expression of BDNF and NGF in rat brain. Peptides. 18:1997;1179-1187.
165. 8]vasopressin in young male and female volunteers. Peptides. 16:1995;179-186.
166. Cole J.L., Berman N., Bodnar R. Evaluation of chronic opioid receptor antagonist effects upon weight and intake measures in lean and obese Zucker rats. Peptides. 18:1997;1201-1207.